Paper36958590
Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents.
Fizazi K and 2 others. Ann Oncol, 2023. Cited by 106 papers, by iCite.
Cite this record
ConductScience Library. Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents. Papers, record 36958590. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36958590
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Neoplasms | Major topic |
| Prostatic Neoplasms, Castration-Resistant | Major topic |
| Male | |
| Humans | |
| Treatment Outcome | |
| Prostate-Specific Antigen |
Source PubMed
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42757692 | Real-world treatment patterns in men with metastatic hormone-sensitive prostate cancer in Europe and Asia between 2020 and 2024. | Oncologist | 2026 | https://conductscience.org/library/papers/42757692 | PubMed |
| 42588618 | Real-World Outcomes of DNA Damage Repair Altered Metastatic Castration-Resistant Prostate Cancer: Insights from FFPE-Based Genomic Profiling. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42588618 | PubMed |
| 42528594 | Genomic Determinants of Lethality and Therapeutic Vulnerability in Castration-Resistant Prostate Cancer. | bioRxiv | 2026 | https://conductscience.org/library/papers/42528594 | PubMed |
| 42449638 | PSMA PET in Lymph Node Staging of Prostate Cancer: From Diagnostic Accuracy to Clinical Decision-Making. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449638 | PubMed |
| 42313080 | Liver Background Uptake of Prostate-specific Membrane Antigen-targeted PET Radiotracers: A Systematic Review and Meta-Analysis. | Radiol Imaging Cancer | 2026 | https://conductscience.org/library/papers/42313080 | PubMed |
| 42279286 | Circulating Tumor DNA as Emerging Predictive and Prognostic Biomarker in Prostate Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42279286 | PubMed |
| 42249939 | Real-world outcomes of [177Lu]Lu-PSMA-I&T in [18F]FDG-positive metastatic castration-resistant prostate cancer: factors related to response and survival. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/42249939 | PubMed |
| 42176182 | Therapy Optimization in mHSPC: Insights from a Multidisciplinary Uro-Oncology Expert Panel. | Adv Ther | 2026 | https://conductscience.org/library/papers/42176182 | PubMed |
| 41979035 | Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01. | Future Oncol | 2026 | https://conductscience.org/library/papers/41979035 | PubMed |
| 41817839 | Stated Preferences for Systemic Treatments for Prostate Cancer: A Targeted Review of the Discrete-Choice Experiment Literature. | Patient | 2026 | https://conductscience.org/library/papers/41817839 | PubMed |
| 41749948 | Malignancy of Urinary Tract in Kidney Transplant Recipients-A Narrative Review. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41749948 | PubMed |
| 41667886 | Treatment patterns in patients with castration-resistant prostate cancer who received darolutamide in the ARAMIS trial in Spain: PARASEC study. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/41667886 | PubMed |
| 41655999 | Feasibility and workflow analysis of confocal microscopy in robot-assisted prostatectomy. | BJU Int | 2026 | https://conductscience.org/library/papers/41655999 | PubMed |
| 41573730 | Editorial: Novel therapeutics for urological cancers. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41573730 | PubMed |
| 41450200 | Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMIS. | Cancer Med | 2026 | https://conductscience.org/library/papers/41450200 | PubMed |
| 41438100 | Pre-PROTO-PRIME: stereotactic body proton therapy to the prostate and pelvic nodes for high-risk and node-positive prostate cancer - feasibility, acute toxicity and dosimetric insights. | Clin Transl Radiat Oncol | 2026 | https://conductscience.org/library/papers/41438100 | PubMed |
| 41385769 | [Immunotherapy for urological cancers in 2025]. | Magy Onkol | 2025 | https://conductscience.org/library/papers/41385769 | PubMed |
| 41097735 | Therapeutic Alliances for Optimizing the Management of Patients with Prostate Cancer: SOGUG Multidisciplinary Expert Panel Recommendations. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41097735 | PubMed |
| 41097690 | Real-Life Use Patterns of Androgen Receptor Pathway Inhibitors (ARPIs): A Nationwide Register-Based Study in Finland During 2012-2023. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41097690 | PubMed |
| 41059299 | A network meta-analysis of the safety of systemic treatments in patients with metastatic hormone-sensitive prostate cancer. | Front Oncol | 2025 | https://conductscience.org/library/papers/41059299 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36958590
GET https://conductscience.org/api/papers/v1/36958590/cited_by?page=2